GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 768 filers reported holding GLAXOSMITHKLINE PLC in Q4 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,097,000 | +20.8% | 71,111 | +20.9% | 0.03% | -15.0% |
| Q1 2022 | $2,563,000 | +544.0% | 58,836 | +555.4% | 0.04% | +566.7% |
| Q4 2021 | $398,000 | -48.2% | 8,977 | -56.0% | 0.01% | -81.2% |
| Q3 2020 | $768,000 | +190.9% | 20,398 | +229.6% | 0.03% | +113.3% |
| Q3 2019 | $264,000 | -55.3% | 6,188 | -56.2% | 0.02% | -62.5% |
| Q1 2019 | $591,000 | -11.5% | 14,139 | -19.2% | 0.04% | -11.1% |
| Q4 2018 | $668,000 | -14.9% | 17,493 | -10.5% | 0.04% | -16.7% |
| Q3 2018 | $785,000 | -0.1% | 19,542 | +0.2% | 0.05% | -6.9% |
| Q2 2018 | $786,000 | +29.7% | 19,501 | +25.8% | 0.06% | +26.1% |
| Q1 2018 | $606,000 | -8.0% | 15,498 | -16.6% | 0.05% | +4.5% |
| Q4 2017 | $659,000 | -38.8% | 18,581 | -29.9% | 0.04% | -42.1% |
| Q3 2017 | $1,076,000 | +101.5% | 26,506 | +114.1% | 0.08% | +68.9% |
| Q2 2017 | $534,000 | +3.5% | 12,378 | +1.2% | 0.04% | +4.7% |
| Q1 2017 | $516,000 | – | 12,234 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |